Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTINE THAI

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1043224587
CMS profile
1470
Location
HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$693.01

43 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $693.01 43

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $254.16 19
Novartis Pharmaceuticals Corporation $154.92 8
ABBVIE INC. $131.14 9
Organon Llc $35.89 2
UCB, Inc. $35.61 2
E.R. Squibb & Sons, L.L.C. $35.54 1
Boehringer Ingelheim Pharmaceuticals, Inc. $25.29 1
PFIZER INC. $20.46 1

Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTINE THAI

NPI 1043224587 · CMS profile ID 1470

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

HUNTINGTON BEACH, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1043224587?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTINE THAI, NPI 1043224587, CMS profile ID 1470. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1043224587?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). CHRISTINE THAI, NPI 1043224587, CMS profile ID 1470. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1043224587?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
CHRISTINE THAI, NPI 1043224587, CMS profile ID 1470, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1043224587?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

43 matching records · $693.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 43 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–43 of 43.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $16.5612/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213378 CMS
Amgen Inc. $11.9412/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723903 CMS
Organon Llc $22.9612/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136296343 CMS
PFIZER INC. $20.4612/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131155743 CMS
Novartis Pharmaceuticals Corporation $17.6711/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396456 CMS
Amgen Inc. $15.5011/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723901 CMS
ABBVIE INC. $29.0911/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213376 CMS
Novartis Pharmaceuticals Corporation $17.0810/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396454 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.2910/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117848005 CMS
Organon Llc $12.9309/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136296341 CMS
Amgen Inc. $13.6809/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723899 CMS
Novartis Pharmaceuticals Corporation $15.1209/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396450 CMS
Amgen Inc. $16.6609/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723883 CMS
ABBVIE INC. $19.7709/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213374 CMS
Amgen Inc. $14.9609/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723897 CMS
Amgen Inc. $13.9308/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723919 CMS
Amgen Inc. $8.0308/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723895 CMS
Novartis Pharmaceuticals Corporation $18.5808/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396448 CMS
UCB, Inc. $18.6408/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143303654 CMS
Amgen Inc. $10.9407/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723917 CMS
ABBVIE INC. $9.9706/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213372 CMS
E.R. Squibb & Sons, L.L.C. $35.5406/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101317810 CMS
Amgen Inc. $8.1706/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723893 CMS
Amgen Inc. $14.7906/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723915 CMS
UCB, Inc. $16.9705/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143303649 CMS
ABBVIE INC. $7.5305/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213370 CMS
Novartis Pharmaceuticals Corporation $23.4305/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396442 CMS
Amgen Inc. $8.9404/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723913 CMS
Novartis Pharmaceuticals Corporation $18.8204/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396430 CMS
Amgen Inc. $9.7604/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723911 CMS
Amgen Inc. $23.2003/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723909 CMS
Amgen Inc. $20.7703/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723891 CMS
Amgen Inc. $15.1703/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723907 CMS
ABBVIE INC. $10.0903/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213368 CMS
Novartis Pharmaceuticals Corporation $23.2503/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396428 CMS
ABBVIE INC. $17.0603/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213366 CMS
Amgen Inc. $6.8703/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723905 CMS
Amgen Inc. $26.3502/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723889 CMS
Amgen Inc. $8.4302/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723887 CMS
ABBVIE INC. $16.7102/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213364 CMS
Novartis Pharmaceuticals Corporation $20.9701/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087396426 CMS
ABBVIE INC. $4.3601/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1106213362 CMS
Amgen Inc. $6.0701/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1111723885 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,357.35 137
PY2020 $1,472.25 78
PY2021 $298.93 19
PY2022 $874.35 56
PY2023 $974.73 69
PY2024 $693.01 43
PY2025 $811.99 35

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,372,053.89 61
PY2024 Recipient $8,444.46 4
PY2024 Principal investigator $1,430,507.12 79
PY2023 Recipient $8,498.49 1
PY2023 Principal investigator $1,858,436.22 86
PY2022 Recipient $72,841.00 2
PY2022 Principal investigator $1,860,641.35 160
PY2021 Recipient $2,012.04 2
PY2021 Principal investigator $577,779.35 91
PY2020 Recipient $2,580.07 2
PY2020 Principal investigator $908,629.40 110
PY2019 Recipient $16,824.73 4
PY2019 Principal investigator $518,505.93 90

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

112 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AbbVie Inc. $7,406.15 12/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721203081
Principal investigator 1 AbbVie Inc. $18,007.18 12/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721203331
Principal investigator 1 AbbVie Inc. $5,313.20 12/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-234 No dispute reported 06/30/2026 721203377
Principal investigator 1 AbbVie Inc. $870.40 12/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721204151
Principal investigator 1 AbbVie Inc. $418.00 12/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721204159
Principal investigator 1 AbbVie Inc. $1,427.92 12/21/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721201581
Principal investigator 1 AbbVie Inc. $9,513.28 12/04/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721199805
Principal investigator 1 AbbVie Inc. $8,880.75 12/03/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M15-991 No dispute reported 06/30/2026 721199309
Principal investigator 1 AbbVie Inc. $200.00 12/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721199115
Principal investigator 1 AbbVie Inc. $1,000.00 12/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721199127
Principal investigator 1 AbbVie Inc. $3,454.88 12/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721199129
Principal investigator 1 AbbVie Inc. $4,824.08 12/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721198239
Principal investigator 1 AbbVie Inc. $8,242.68 12/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721198673
Principal investigator 1 AbbVie Inc. $2,085.28 12/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721198677
Principal investigator 1 AbbVie Inc. $800.00 11/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721197333
Principal investigator 1 AbbVie Inc. $9,133.90 11/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-675 No dispute reported 06/30/2026 721197451
Principal investigator 1 AbbVie Inc. $15,774.86 11/12/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721195423
Principal investigator 1 AbbVie Inc. $7,192.80 11/10/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721194909
Principal investigator 1 AbbVie Inc. $7,192.80 11/10/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721194911
Principal investigator 1 AbbVie Inc. $4,852.22 11/03/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721194307
Principal investigator 1 AbbVie Inc. $7,475.65 10/29/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721193105
Principal investigator 1 AbbVie Inc. $3,361.50 10/29/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721193107
Principal investigator 1 AbbVie Inc. $4,507.88 10/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721193163
Principal investigator 1 AbbVie Inc. $4,626.24 10/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721193741
Principal investigator 1 Eli Lilly and Company $306,489.00 10/26/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
A PHASE 3 RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 IN PREVENTING SARS COV 2 INFECTION AND COVID 19 IN SKILLED NURSING AND ASSISTED LIVING FACILITY RESIDENTS AND STAFF A NIAID AND LILLY COLLABORATIVE STUDY No dispute reported 06/30/2026 728737659
Principal investigator 1 AbbVie Inc. $475.00 10/22/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721191931
Principal investigator 1 AbbVie Inc. $3,451.04 10/19/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721191445
Principal investigator 1 AbbVie Inc. $600.00 10/13/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721190809
Principal investigator 1 AbbVie Inc. $170.00 10/13/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721190811
Principal investigator 1 AbbVie Inc. $14,488.89 10/06/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721190313
Principal investigator 1 AbbVie Inc. $3,540.00 10/02/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721189965
Principal investigator 1 AbbVie Inc. $3,311.25 09/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721188543
Principal investigator 1 AbbVie Inc. $5,810.74 09/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721188627
Principal investigator 1 AbbVie Inc. $3,623.40 09/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-675 No dispute reported 06/30/2026 721188837
Principal investigator 1 AbbVie Inc. $44.80 09/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721187571
Principal investigator 1 AbbVie Inc. $15,792.59 09/03/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721185195
Principal investigator 1 AbbVie Inc. $2,855.84 09/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721184685
Principal investigator 1 AbbVie Inc. $6,195.50 09/01/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-675 No dispute reported 06/30/2026 721184451
Principal investigator 1 AbbVie Inc. $4,878.93 08/28/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721183227
Principal investigator 1 AbbVie Inc. $5,846.24 08/28/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721183283
Principal investigator 1 AbbVie Inc. $750.00 08/26/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721182303
Principal investigator 1 AbbVie Inc. $14,467.82 08/13/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721180815
Recipient Eli Lilly and Company $141.50 08/10/2020 Covered Recipient Physician A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 728717601
Principal investigator 1 AbbVie Inc. $10,110.47 08/05/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721179843
Principal investigator 1 AbbVie Inc. $2,895.52 07/31/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721178985
Principal investigator 1 AbbVie Inc. $11,673.64 07/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721177957
Principal investigator 1 AbbVie Inc. $17,874.15 07/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-675 No dispute reported 06/30/2026 721178073
Principal investigator 1 AbbVie Inc. $2,623.74 07/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721177279
Principal investigator 1 AbbVie Inc. $12,403.80 07/22/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721176465
Principal investigator 1 AbbVie Inc. $75.00 07/16/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721176095
Principal investigator 1 AbbVie Inc. $1,025.00 07/15/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721175999
Principal investigator 1 AbbVie Inc. $1,608.79 07/07/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721175277
Principal investigator 1 AbbVie Inc. $170.00 07/07/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721175351
Principal investigator 1 AbbVie Inc. $8,373.76 07/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721174009
Principal investigator 1 AbbVie Inc. $5,193.45 06/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721173275
Principal investigator 1 AbbVie Inc. $9,358.45 06/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M16-006 No dispute reported 06/30/2026 721173375
Principal investigator 1 AbbVie Inc. $9,866.16 06/30/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M14-675 No dispute reported 06/30/2026 721173407
Principal investigator 1 AbbVie Inc. $661.76 06/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721173737
Principal investigator 1 AbbVie Inc. $850.00 06/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721173741
Principal investigator 1 AbbVie Inc. $2,106.62 06/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721173743
Principal investigator 1 AbbVie Inc. $1,683.92 06/22/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721171957
Principal investigator 1 AbbVie Inc. $252.94 06/11/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721170981
Principal investigator 1 AbbVie Inc. $7,192.80 06/10/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721170633
Principal investigator 1 AbbVie Inc. $44,211.40 06/10/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721170675
Principal investigator 1 AbbVie Inc. $1,608.79 06/04/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721170375
Principal investigator 1 AbbVie Inc. $2,421.02 06/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721169761
Principal investigator 1 AbbVie Inc. $6,583.08 05/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721168673
Principal investigator 1 AbbVie Inc. $7,572.98 05/29/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721168991
Principal investigator 1 AbbVie Inc. $3,862.40 05/28/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721168101
Principal investigator 1 AbbVie Inc. $2,049.00 05/21/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721166619
Principal investigator 1 AbbVie Inc. $250.00 05/21/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721166625
Principal investigator 1 AbbVie Inc. $4,729.08 05/15/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721166131
Principal investigator 1 AbbVie Inc. $1,000.00 05/07/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721165659
Principal investigator 1 AbbVie Inc. $350.00 05/07/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721165661
Principal investigator 1 AbbVie Inc. $12,328.52 05/06/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721165423
Principal investigator 1 AbbVie Inc. $3,407.52 05/01/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721164803
Principal investigator 1 AbbVie Inc. $2,653.80 04/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721163693
Principal investigator 1 AbbVie Inc. $11,829.56 04/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721163761
Principal investigator 1 AbbVie Inc. $1,000.00 04/28/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721162631
Principal investigator 1 AbbVie Inc. $2,150.14 04/27/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721162489
Principal investigator 1 AbbVie Inc. $250.00 04/22/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721161795
Principal investigator 1 Eli Lilly and Company $237.95 04/08/2020 Non-covered Recipient Entity
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 728738381
Principal investigator 1 AbbVie Inc. $4,683.85 04/03/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721159995
Principal investigator 1 AbbVie Inc. $752.30 03/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721158283
Principal investigator 1 AbbVie Inc. $14,628.88 03/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721158371
Principal investigator 1 AbbVie Inc. $1,427.92 03/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721158947
Principal investigator 1 AbbVie Inc. $2,623.74 03/27/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721157429
Principal investigator 1 Eli Lilly and Company $56.68 03/24/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 728738913
Principal investigator 1 AbbVie Inc. $9,185.52 03/13/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721155809
Principal investigator 1 AbbVie Inc. $1,050.00 03/12/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721155647
Principal investigator 1 AbbVie Inc. $2,239.00 03/05/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M19-944 No dispute reported 06/30/2026 721154823
Principal investigator 1 AbbVie Inc. $2,392.32 03/04/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721154393
Principal investigator 1 Eli Lilly and Company $18,572.00 03/03/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 728738909
Principal investigator 1 AbbVie Inc. $1,901.50 02/28/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721153157
Principal investigator 1 AbbVie Inc. $12,991.64 02/28/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721153237
Principal investigator 1 AbbVie Inc. $3,095.20 02/28/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721153803
Recipient Eli Lilly and Company $2,438.57 02/25/2020 Covered Recipient Physician A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE- CONTROLLED, TREAT-THROUGH STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE No dispute reported 06/30/2026 728718499
Principal investigator 1 AbbVie Inc. $5,500.00 02/24/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
M16-006 No dispute reported 06/30/2026 721151849
Principal investigator 1 AbbVie Inc. $2,623.74 02/20/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721151643
Principal investigator 1 AbbVie Inc. $300.00 02/14/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-572 No dispute reported 06/30/2026 721150721
Principal investigator 1 AbbVie Inc. $2,642.94 02/04/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721149513
Principal investigator 1 AbbVie Inc. $1,471.44 01/31/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721148965
Principal investigator 1 AbbVie Inc. $2,256.90 01/30/2020 Non-covered Recipient Entity
MERIDIAN INVESTIGATOR NETWORK LLC
M15-722 No dispute reported 06/30/2026 721148151
Principal investigator 1 AbbVie Inc. $15,728.72 01/30/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721148213
Principal investigator 1 Eli Lilly and Company $33,800.00 01/28/2020 Non-covered Recipient Entity
NEWPORT HUNTINGTON MEDICAL GROUP
A RANDOMIZED, ACTIVE-CONTROLLED, PARALLEL-GROUP, PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS No dispute reported 06/30/2026 728734993
Principal investigator 1 Eli Lilly and Company $549.00 01/28/2020 Non-covered Recipient Entity
VANCOUVER CLINIC INC PS
A MULTICENTER LONG-TERM EXTENSION STUDY OF 104 WEEKS INCLUDING A DOUBLE BLIND PLACEBO CONTROLLED 40 WEEK RANDOMIZED WITHDRAWAL RETREATMENT PERIOD TO EVALUATE THE MAINTENANCE OF TREATMENT EFFECT OF IXEKIZUMAB LY2439821 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS No dispute reported 06/30/2026 728750137
Principal investigator 1 Eli Lilly and Company $2,500.00 01/13/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
A 52 WEEK MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IXEKIZUMAB LY2439821 IN BDMARD NAIVE PATIENTS WITH NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS No dispute reported 06/30/2026 728733615
Principal investigator 1 AbbVie Inc. $116.33 01/10/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-998 No dispute reported 06/30/2026 721144937
Principal investigator 1 Eli Lilly and Company $17,013.00 01/06/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
A MULTICENTER LONG-TERM EXTENSION STUDY OF 104 WEEKS INCLUDING A DOUBLE BLIND PLACEBO CONTROLLED 40 WEEK RANDOMIZED WITHDRAWAL RETREATMENT PERIOD TO EVALUATE THE MAINTENANCE OF TREATMENT EFFECT OF IXEKIZUMAB LY2439821 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS No dispute reported 06/30/2026 728733611
Principal investigator 1 AbbVie Inc. $226.58 01/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721144083
Principal investigator 1 AbbVie Inc. $2,603.26 01/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-554 No dispute reported 06/30/2026 721144085
Principal investigator 1 AbbVie Inc. $1,849.04 01/02/2020 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
M15-925 No dispute reported 06/30/2026 721144095